The Lancet Diabetes and Endocrinology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Diabetes education: the key to a brighter tomorrow

doi : 10.1016/S2213-8587(22)00323-0

Volume 10, Issue 12, December 2022, Page 827

Buy The Package and View The Article Online


Trending now: modelling global epidemiology of type 1 diabetes in children and adolescents

doi : 10.1016/S2213-8587(22)00306-0

Volume 10, Issue 12, December 2022, Pages 828-829

Buy The Package and View The Article Online


Setmelanotide for controlling weight and hunger in Bardet-Biedl syndrome

Maithe Tauber a b

doi : 10.1016/S2213-8587(22)00309-6

Buy The Package and View The Article Online


Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status

Hertzel C Gerstein a, Naveed Sattar b

doi : 10.1016/S2213-8587(22)00313-8

Buy The Package and View The Article Online


The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news

Rossella E Nappi a b

doi : 10.1016/S2213-8587(22)00285-6

Buy The Package and View The Article Online


Open-source automated insulin delivery in type 1 diabetes—the evidence is out there

Sufyan Hussain a b c, Rayhan A Lal d, Katarina Braune e f

doi : 10.1016/S2213-8587(22)00283-2

Buy The Package and View The Article Online


COP27 Climate Change Conference: urgent action needed for Africa and the world

doi : 10.1016/S2213-8587(22)00305-9

Volume 10, Issue 12, December 2022, Pages 837-839

Buy The Package and View The Article Online


Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes

doi : 10.1016/S2213-8587(22)00312-6

Volume 10, Issue 12, December 2022, Page 840

Buy The Package and View The Article Online


Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes

doi : 10.1016/S2213-8587(22)00311-4

Volume 10, Issue 12, December 2022, Pages 840-841

Buy The Package and View The Article Online


Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes – Authors' reply

doi : 10.1016/S2213-8587(22)00310-2

Volume 10, Issue 12, December 2022, Pages 841-842

Buy The Package and View The Article Online


Prequalification of insulin: what is missing?

doi : 10.1016/S2213-8587(22)00316-3

Volume 10, Issue 12, December 2022, Pages 842-843

Buy The Package and View The Article Online


Lorenz Hofbauer: connecting the unexpected

doi : 10.1016/S2213-8587(22)00321-7

Volume 10, Issue 12, December 2022, Page 844

Buy The Package and View The Article Online


Social media and misinformation in diabetes and obesity

doi : 10.1016/S2213-8587(22)00318-7

Volume 10, Issue 12, December 2022, Page 845

Buy The Package and View The Article Online


Gestational diabetes in Australia: navigating a tsunami

doi : 10.1016/S2213-8587(22)00284-4

Volume 10, Issue 12, December 2022, Pages 846-847

Buy The Package and View The Article Online


Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis

doi : 10.1016/S2213-8587(22)00276-5

Volume 10, Issue 12, December 2022, Pages 848-858

Buy The Package and View The Article Online


Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period

Prof Andrea M Haqq MD a, Prof Wendy K Chung MD b, Prof Hélène Dollfus MD c, Robert M Haws MD d, Gabriel � Martos-Moreno MD e, Prof Christine Poitou MD f g, Prof Jack A Yanovski MD h, Robert S Mittleman MD i, Guojun Yuan PhD i, Elizabeth Forsythe MD j, Prof Karine Clément MD f g, Prof Jesús Argente MD a k

doi : 10.1016/S2213-8587(22)00277-7

Buy The Package and View The Article Online


Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial

Prof Silvio E Inzucchi MD a, Brian L Claggett PhD b, Muthiah Vaduganathan MD b, Akshay S Desai MD b, Prof Pardeep S Jhund PhD c, Prof Rudolf A de Boer MD d, Prof Adrian F Hernandez MD e, Prof Mikhail N Kosiborod MD f, Prof Carolyn S P Lam MBBS g, Prof Felipe Martinez MD h, Prof Sanjiv J Shah MD i, Prof Subodh Verma PhD j, Prof Yaling Han PhD k, Prof Jose F Kerr Saraiva PhD l, Olof Bengtsson Ph Lic m, Magnus Petersson PhD m, Anna Maria Langkilde PhD m, Prof John J V McMurray MD c, Prof Scott D Solomon MD b

doi : 10.1016/S2213-8587(22)00308-4

Buy The Package and View The Article Online


Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history

Prof Angelo Avogaro PhD MD a, Saula Vigili de Kreutzenberg PhD a, Mario Luca Morieri PhD MD a, Prof Gian Paolo Fadini PhD MD a, Prof Stefano Del Prato MD b

doi : 10.1016/S2213-8587(22)00247-9

Buy The Package and View The Article Online


The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery

doi : 10.1016/S2213-8587(22)00278-9

Volume 10, Issue 12, December 2022, Pages 890-900

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?